3Fleischmajer R,Kuroda K,Hazan R,et al.Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2.J Invest Dermatol,2000,115:771-777.
4Suomela S,Kariniemi AL,Snellman E,et al.Metalloelastase(MMP-12)and 92-kDa gelatinase (MMP-9)as well as their inhibitors,TIMP-1 and -3,are expre ssed in psoriatic lesions.Exp Dermatol,2001,10:175-183.
5Suomela S,Kariniemi AL,Impola U,et al.Matrix metalloproteinase-19 is expressed by keratinocytes in psoriasis.Acta Derm Venereol,2003,83:108-114.
6Giannelli G,Brassard J,Foti C,et al.Altered expression of basement membrane proteins and their integrin receptors in lichen planus:possible pathogenetic role of gelatinases A and B.Lab Invest,1996,74:1091-1104.
7Zhou XJ,Sugerman PB,Savage NW,et al.Matrix metalloproteinases and their inhibitors in oral lichen planus.J Cutan Pathol,2001,28:72-82.
8Katoh N,Hirano S,Suehiro M,et al.Increased levels of serum tissue inhibitor of metalloproteinase-1 but not metalloproteinase-3 in atopic dermatitis.Clin Exp Immunol,2002,127:283-288.
9Heffler LC,Kastman AL,Jacobsson Ekman G,et al.Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenyl cyclopropenone in patients with alopecia areata.Br J Dermatol,2002,147:222-229.
10Giannelli G,Foti C,Marinoci F,et al.Gelatinase expression at positive patch test reactions.Contact Dermatitis.2002,46:280-285.
二级参考文献1
1David E. Kleiner,William G. Stetler-Stevenson. Matrix metalloproteinases and metastasis[J] 1999,Cancer Chemotherapy and Pharmacology(1):S42～S51
2ZhouCX,Gao Y,Johnson NW,et al.Immunoexpression ofmatrix metalloproteinase-2 and matrix metalloproteinase-9 inthemetastasis of squamous cell carcinoma of the humantongue[J].Aust Dent J,2010,55(4):385-389.
3ZhongWD,Han ZD,He HC,et al.CD147,MMP-l,MMP-2 andMMP-9 protein expression as significant prognostic factorsin human prostate cancer[J].Am J Pediatr Hematol Oncol,2008,75(3-4):230-236.
4GroblewskaM,Siewko M,Mroczko B,et al.The role of matrixmetalloproteinases(MMPs)and their inhibitors(TIMPs)inthe development of esophageal cancer[J].Folia HistochemCytobiol,2012,50(1):12-19.
5MooreCS,Crocker SJ.An alternate perspective on the rolesof TIMPs and MMPs in pathology[J].Am J Pathol,2012,180(1):12-16.
6SatoH,Takino T.Coordinate action of membrane-typematrix metalloproteinase-1(MT1-MMP)and MMP-2enhances pericellular proteolysis and invasion[J].CancerSci,2010,101(4):843-847.
7AbdouAG,Maraee AH,A1-Bara AM,et al.Immxmohistochemical expression of TGF-β1 in keloids andhypertrophic scars[J].Am J Dermatopathol,2011,33(1):84-91.
8EissaS,Ali-labib R,Swellan M,et al.Noninvasivediagnosis of bladder cancer by detection of matrixmetalloproteinases(MMP-2 and MMP-9)and theirinhibitor(TIMP-2)in urine[J].European Urology,2007,52(5):1388-1397.
9UlrichD,Ulrich F,Unglaub F,et al.Matrixmetalloproteinases and tissue inhibitors ofmetalloproteinases in patients with different types of scarsand keloids[J].J Plast Reconstr Aesthet Surg,2010,63(6):1015-1021.
10DangCM,Beanes SR,Lee H,et al.Scarless fetal wounds areassociated with an increased matrixmetalloproteinase-to-tissue-derived inhibitor ofmetalloproteinase ratio[J].Plast Reconstr Surg,2003,lll(7):2273-2285.
